Cellebrite DI (CLBT) Accumulated Expenses (2020 - 2026)

Cellebrite DI has reported Accumulated Expenses for 7 years, with the latest figure at $77.0 million in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 13.3% year-over-year to $77.0 million in Q2 2026; TTM through Jun 2026 was $77.0 million, a 13.3% increase from a year earlier, with the FY2025 full-year figure at $71.2 million, up 12.5% from the prior year.
• Accumulated Expenses was $77.0 million for Q2 2026 at Cellebrite DI, down from $79.7 million in the prior quarter.
• The five-year high for Accumulated Expenses was $79.7 million in Q1 2026, with the low at $35.6 million in Q2 2023.
• Average Accumulated Expenses over 5 years is $53.1 million, with a median of $48.4 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses dropped 24.94% in 2023, then soared 60.84% in 2025.
• Over 5 years, Accumulated Expenses stood at $45.5 million in 2022, then decreased by 1.34% to $44.8 million in 2023, then surged by 41.22% to $63.3 million in 2024, then grew by 12.5% to $71.2 million in 2025, then rose by 8.09% to $77.0 million in 2026.
• The last three Accumulated Expenses figures came in at $77.0 million (Q2 2026), $79.7 million (Q1 2026), and $71.2 million (Q4 2025), per Business Quant data.